fda tirzepatide injection shortage resolved oct 2 2024 Announced Removal of from the Drug List FDA says shortage of GLP-1

doi: 10.1016/j.carbpol.2022.120153 103

The standard injection schedule reaches a target maintenance dose of 2.4 mg after approximately 16 weeks

Lifestyle & Behavioral Programs as a Stepping Stone For long term health, GLP-1s are best used with a comprehensive metabolic health strategy

As the trial was not designed to assess the increased values of ALT and AST, it was not possible to distinguish between an effect of repeated OC treatments and the effect of co-administration of OC and oral semaglutide

Current evidence does not show harm from combining these two approaches, but studies specifically examining the combination in humans remain limited

Medullary thyroid cancer in humans has remained rare and unchanged for 30+ years, he noted